Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | EVP, Human Resources | December 02, 2024 | December 04, 2024 |
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date December 02, 2024 · Filed December 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,308 |
Ending reported balance
After 2024-12-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-12-02 · Exercise / conversion · Acquired 3,066 · Balance 35,094 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Row 2 · 2024-12-02 · Exercise / conversion · Acquired 1,197 · Balance 36,291 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Row 3 · 2024-12-02 · Sale · Disposed 6,983 · Balance 29,308 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.26 · Expires 2026-02-22 | Direct | 0 |
Reported balance
After 2024-12-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-12-02 · Exercise / conversion · Disposed 3,066 · Balance 0 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.55 · Expires 2027-02-28 | Direct | 13,183 |
Reported balance
After 2024-12-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-12-02 · Exercise / conversion · Disposed 1,197 · Balance 13,183 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.
F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,940 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 59,940 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 21, 2026 20:37 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001563565-26-000003 · wk-form4_1779395847.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,940 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031064 · wk-form4_1749761718.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,610 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-010528 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,183 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-010528 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $90.78 | $633,916.74 |
DisclosureSEC source: 0001225208-24-010528 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,308 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-010528 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-010528 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:09 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-009605 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,380 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:09 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-009605 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,066 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:09 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $84.33 | $588,876.39 |
DisclosureSEC source: 0001225208-24-009605 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,028 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:09 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-009605 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:09 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-009605 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:22 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-009021 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,577 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:22 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-009021 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,132 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:22 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $83.86 | $585,594.38 |
DisclosureSEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,748 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:22 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:22 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-008333 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,774 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-008333 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,198 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $81.70 | $570,511.10 |
DisclosureSEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,468 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-007778 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,971 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-007778 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,264 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $74.12 | $517,579.96 |
DisclosureSEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,188 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 21:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-007196 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,168 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-007196 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,330 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $77.30 | $539,785.90 |
DisclosureSEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,908 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:13 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 21:39 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-006513 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,365 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 21:39 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-006513 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,396 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 21:39 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $75.33 | $526,029.39 |
DisclosureSEC source: 0001225208-24-006513 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,628 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 21:39 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-006513 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 21:39 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-006513 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000054 · wk-form4_1716496448.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,160 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:42 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-005478 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,562 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:42 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-005478 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,462 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:42 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $71.47 | $499,075.01 |
DisclosureSEC source: 0001225208-24-005478 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,348 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:42 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-005478 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:42 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-005478 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:57 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-004848 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,759 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:57 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-004848 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,528 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:57 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 6,983 | $68.42 | $477,776.86 |
DisclosureSEC source: 0001225208-24-004848 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,068 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:57 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,197 | $24.55 | $29,386.35 |
DisclosureSEC source: 0001225208-24-004848 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:57 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,066 | $17.26 | $52,919.16 |
DisclosureSEC source: 0001225208-24-004848 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:50 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $24.55 | $0.00 |
DisclosureSEC source: 0001225208-24-003504 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,956 Underlying: Common Stock · 1,197 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:50 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-24-003504 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,594 Underlying: Common Stock · 3,066 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.